All Stories

  1. Why Does Clostridium difficile Infection Recur?

    Article • Journal of Osteopathic Medicine, May 2019, De Gruyter

    DR Robert Orenstein

  2. Clostridioides difficile therapeutics: guidelines and beyond

    Article • Therapeutic Advances in Infectious Disease, January 2019, SAGE Publications

    DR Robert Orenstein

  3. Preoperative risk prediction of surgical site infection requiring hospitalization or reoperation in patients undergoing vascular surgery

    Article • Journal of Vascular Surgery, July 2016, Elsevier

    DR Robert Orenstein

  4. Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient

    Article • Journal of Osteopathic Medicine, June 2016, De Gruyter

    DR Robert Orenstein

  5. ENGAGE Initiative: Showcasing Osteopathic Scholarly Activity

    Article • Journal of Osteopathic Medicine, May 2016, De Gruyter

    DR Robert Orenstein

  6. Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility

    Article • Microbiome, February 2016, Springer Science + Business Media

    DR Robert Orenstein

  7. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study

    Article • Clinical Infectious Diseases, November 2015, Oxford University Press (OUP)

    DR Robert Orenstein

  8. Coccidioidal Tenosynovitis of the Hand and Wrist: Report of 9 Cases and Review of the Literature: Table 1.

    Article • Clinical Infectious Diseases, August 2015, Oxford University Press (OUP)

    DR Robert Orenstein

  9. The JAOA: Growing, Changing, Improving

    Article • Journal of Osteopathic Medicine, April 2015, De Gruyter

    DR Robert Orenstein

  10. Emerging Infections: The Cauldron of Medicine, Mobility, and Media

    Article • Journal of Osteopathic Medicine, November 2014, De Gruyter

    DR Robert Orenstein

  11. Introducing the New JAOA Editorial Team

    Article • Journal of Osteopathic Medicine, August 2014, De Gruyter

    DR Robert Orenstein

  12. Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis

    Article • Emerging Infectious Diseases, June 2014, Centers for Disease Control and Prevention (CDC)

    DR Robert Orenstein

  13. The Journal of the American Osteopathic Association: The Next Generation

    Article • Journal of Osteopathic Medicine, May 2014, De Gruyter

    DR Robert Orenstein

  14. Patient and Environmental Service Employee Satisfaction of Using Germicidal Bleach Wipes for Patient Room Cleaning

    Article • Journal for Healthcare Quality, November 2013, Wolters Kluwer Health

    DR Robert Orenstein

  15. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection: Mayo Clinic in Arizona Experience

    Article • Mayo Clinic Proceedings, August 2013, Elsevier

    DR Robert Orenstein

  16. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis

    Article • Journal of Infection, August 2013, Elsevier

    DR Robert Orenstein

  17. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: Admission prevalence and risk factors

    Article • American Journal of Infection Control, May 2013, Elsevier

    Surbhi Leekha, DR Robert Orenstein

  18. A Randomized, Double Blind, Placebo‐Controlled Trial of an Oral Synbiotic (AKSB) for Prevention of Travelers' Diarrhea

    Article • Journal of Travel Medicine, March 2013, Oxford University Press (OUP)

    DR Robert Orenstein

  19. Immunology: Zoster vaccine and biologic agents: time to question a paradigm?

    Article • Nature Reviews Rheumatology, October 2012, Nature

    DR Robert Orenstein

  20. Infectious Diarrhea

    Article • January 2012, Oxford University Press (OUP)

    DR Robert Orenstein

  21. Intra-abdominal Infections

    Article • January 2012, Oxford University Press (OUP)

    DR Robert Orenstein

  22. Corrigendum: The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

    Article • The American Journal of Gastroenterology, January 2012, Nature

    DR Robert Orenstein

  23. The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study

    Article • The American Journal of Gastroenterology, November 2011, Nature

    DR Robert Orenstein

  24. A Targeted Strategy to Wipe Out Clostridium difficile

    Article • Infection Control, November 2011, Cambridge University Press

    DR Robert Orenstein

  25. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009

    Article • BMC Infectious Diseases, May 2011, Springer Science + Business Media

    DR Robert Orenstein

  26. Clinical Syndromes in Infectious Diseases

    Article • August 2010, Oxford University Press (OUP)

    DR Robert Orenstein

  27. Disseminated sporotrichosis

    Article • Journal of Hospital Medicine, March 2010, Frontline Medical Communications, Inc.

    DR Robert Orenstein

  28. An outbreak of Mycobacterium chelonae infections in tattoos

    Article • Journal of the American Academy of Dermatology, March 2010, Elsevier

    DR Robert Orenstein

  29. Clinical Pearls in Infectious Diseases

    Article • Mayo Clinic Proceedings, February 2010, Elsevier

    DR Robert Orenstein

  30. High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity

    Article • Diagnostic Microbiology and Infectious Disease, January 2010, Elsevier

    DR Robert Orenstein

  31. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study

    Article • The Lancet Neurology, January 2010, Elsevier

    DR Robert Orenstein

  32. Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?

    Article • Nature Reviews Rheumatology, July 2009, Nature

    DR Robert Orenstein

  33. Effect of Telephoned Notification of Positive Clostridium difficile Test Results on the Time to the Ordering of Antimicrobial Therapy

    Article • Infection Control, July 2008, Cambridge University Press

    DR Robert Orenstein

  34. Infectious Diseases

    Article • June 2008, Taylor & Francis

    DR Robert Orenstein

  35. Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

    Article • Gastroenterology, April 2008, Elsevier

    DR Robert Orenstein

  36. Opportunistic infections associated with TNF-α treatment

    Article • Future Rheumatology, December 2007, Future Medicine

    DR Robert Orenstein

  37. Infectious Diseases

    Article • November 2007, Taylor & Francis

    DR Robert Orenstein

  38. Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies

    Article • Muscle & Nerve, January 2007, Wiley

    DR Robert Orenstein

  39. Proteus mirabilis: A rare cause of infectious endocarditis

    Article • Scandinavian Journal of Infectious Diseases, January 2007, Taylor & Francis

    DR Robert Orenstein

  40. Infections related to TNF-α inhibitors

    Article • Expert Review of Dermatology, October 2006, Taylor & Francis

    DR Robert Orenstein

  41. A Woman with Fever and Rash after African Safari

    Article • Clinical Infectious Diseases, September 2006, Oxford University Press (OUP)

    DR Robert Orenstein

  42. Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century

    Article • Mayo Clinic Proceedings, February 2006, Elsevier

    DR Robert Orenstein

  43. Travel in patients receiving TNF-alpha inhibitors

    Article • Travel Medicine and Infectious Disease, May 2005, Elsevier

    DR Robert Orenstein

  44. Tumor necrosis factor antagonists and infections: The small print on the price tag

    Article • Arthritis & Rheumatism, January 2005, Wiley

    DR Robert Orenstein

  45. Successful Treatment of Disseminated Nonmeningeal Coccidioidomycosis with Voriconazole

    Article • Clinical Infectious Diseases, October 2004, Oxford University Press (OUP)

    DR Robert Orenstein

  46. HIV Infection in Primary Care

    Article • Mayo Clinic Proceedings, April 2003, Elsevier

    DR Robert Orenstein

  47. Looking Beyond Highly Active Antiretroviral Therapy: Drug-Related Hepatotoxicity in Patients with Human Immunodeficiency Virus Infection

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2002, Wiley

    DR Robert Orenstein

  48. Presenting Syndromes of Human Immunodeficiency Virus

    Article • Mayo Clinic Proceedings, October 2002, Elsevier

    DR Robert Orenstein

  49. The spectrum of hepatitis C virus (HCV) in human immunodeficiency virus (HIV) coinfection: Stratification by stage and immune function

    Article • Gastroenterology, April 2001, Elsevier

    DR Robert Orenstein

  50. Doxycycline for Switch Therapy in Community- Acquired Pneumonia

    Article • Infectious Diseases in Clinical Practice, December 1999, Wolters Kluwer Health

    DR Robert Orenstein

  51. Bacterial Complications of Strongyloidiasis: Streptococcus bovis Meningitis

    Article • Southern Medical Journal, July 1999, Southern Medical Association

    DR Robert Orenstein

  52. Risk Factors for Urinary Lithotripsy-Associated Sepsis

    Article • Infection Control, August 1993, JSTOR

    DR Robert Orenstein

  53. Risk Factors for Urinary Lithotripsy-Associated Sepsis

    Article • Infection Control, August 1993, Cambridge University Press

    DR Robert Orenstein

  54. Invasive Haemophilus influenzae

    Article • Annals of Internal Medicine, October 1992, American College of Physicians

    DR Robert Orenstein